Q linea

Q linea Book Value per Share

The Book Value per Share of Q linea (QLINEA.ST) as of Nov 16, 2026 is 52.51 SEK. In the previous year, Book Value per Share was -4.27 SEK — a change of -1,331.08% (higher).

Book Value per Share

52.51SEK

YoY

-1,331.08%

Last updated:

Book Value per Share of Q linea is 2025 52.51 SEK. Book Value per Share of Q linea was 2024 -4.27 SEK. It decreases by -1,331.08% higher compared to the previous year.

The Q linea Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2018
79.77 SEK
Jan 1, 2019
52.97 SEK
Jan 1, 2020
59.07 SEK
Jan 1, 2021
66.92 SEK
Jan 1, 2022
25.11 SEK
Jan 1, 2023
29.46 SEK
Jan 1, 2024
-4.27 SEK
Jan 1, 2025
52.51 SEK
The Q linea Book Value per Share history
YEARBook Value per ShareYoY
52.51SEK-1,331.08%
-4.27SEK-114.48%
29.46SEK+17.33%
25.11SEK-62.48%
66.92SEK+13.31%
59.07SEK+11.51%
52.97SEK-33.60%
79.77SEK+33,858.86%
0.23SEK-82.11%
1.31SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Q linea Stock analysis

What does Q linea do? Q-linea AB develops and manufactures in-vitro diagnostic solutions for infectious diseases, focusing on antibiotic susceptibility testing. The company's core product, ASTar, is a fully-automated instrument that provides susceptibility profiles within three to six hours directly from positive blood cultures. This enables early targeted antibiotic administration for sepsis identification in hospital patients, primarily serving hospital laboratories. The firm measures bacteria's antimicrobial susceptibility using its own disposables, which are integral to the ASTar system's operation. Q-linea AB's revenue model is based on selling the ASTar instrument and its associated disposables to hospital laboratories. The company's product is specifically designed for sepsis identification in hospital settings, where rapid and accurate antibiotic susceptibility testing is critical. By providing a faster solution than traditional methods, Q-linea targets hospital labs seeking to improve patient outcomes in sepsis cases. The company operates as a holding company with a focus on developing and manufacturing IVD solutions. Its primary customers are hospital laboratories, which purchase the ASTar system and disposables to streamline their diagnostic processes. The firm's business model centers on the sale of both the instrument and the consumable disposables, creating recurring revenue streams from ongoing disposables usage. Q linea is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Q linea stock

Book Value per Share of Q linea is 52.51 SEK in 2025.

Book Value per Share of Q linea changed from -4.27 SEK to 52.51 SEK, representing a -1,331.08% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Q linea since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Q linea

All Key Metrics — Q linea